Search Results - "Moşescu, Simona"
-
1
Genetic and clinical factors influencing CF-associated liver disease: the impact of SERPINA1 variants and CFTR genotypes in Romanian pediatric cystic fibrosis patients
Published in Medicine and pharmacy reports (01-10-2024)“…Background. Hepatic disease represents a significant complication in children with cystic fibrosis (CF), yet its relationship with specific genetic factors,…”
Get full text
Journal Article -
2
Impact of CFTR Modulator Therapies on Liver Function in Cystic Fibrosis Patients: A Systematic Review of Hepatic Biomarkers
Published in Journal of gastrointestinal and liver diseases : JGLD (10-09-2024)“…Background and Aims: Cystic fibrosis transmembrane conductance regulator (CFTR) modulators, including elexacaftor/ivacaftor/tezacaftor (ETI) and…”
Get full text
Journal Article -
3
A case report of an organic foreign body aspiration in a young child-bridging the gap between anamnestic, clinical and radiological aspects
Published in Revista română de pediatrie (31-03-2024)“…Foreign body aspiration occurs more frequently in young children due to immature anatomical and functional structures like underdeveloped mechanism of…”
Get full text
Journal Article -
4
DETERMINAREA CONDUCTIVITĂŢII SUDORII ÎN DIAGNOSTICUL FIBROZEI CHISTICE – EXPERIENŢA CENTRULUI REGIONAL SCUC „GRIGORE ALEXANDRESCU
Published in Revista română de pediatrie (30-06-2017)Get full text
Journal Article -
5
SWEAT CONDUCTIVITY IN THE DIAGNOSIS OF CYSTIC FIBROSIS – THE EXPERIENCE OF THE REGIONAL CENTRE “GRIGORE ALEXANDRESCU” EMERGENCY CHILDREN’S HOSPITAL
Published in Revista română de pediatrie (30-06-2017)“…Introduction. The sweat test is the standard method for the diagnosis of cystic fibrosis (CF). The sweat conductivity represents an alternative not yet…”
Get full text
Journal Article -
6
Clinical and laboratory correlations in patients with cystic fibrosis and Pseudomonas aeruginosa infection: The experience of a regional centre
Published in Pneumologia (Bucharest, Romania) (01-10-2016)“…Pseudomonas aeruginosa (Pa) is the most important pathogen affecting the prognosis of patients with cystic fibrosis (CF). Distinguishing the correlations…”
Get more information
Journal Article -
7
The study of cystic fibrosis transmembrane conductance regulator gene mutations in a group of patients from Romania
Published in Journal of cystic fibrosis (01-09-2008)“…Abstract Background Cystic fibrosis (CF) is produced by mutations in the Cystic Fibrosis Transmembrane Conductance Regulator Gene (CFTR) gene. Methods One…”
Get full text
Journal Article -
8
P50Diagnostic problems in a case of incomplete kawasaki disease
Published in Archives of disease in childhood (01-06-2017)“…IntroductionKawaski disease (KD) is the second most common vasculitis of the childhood. The clinical criteria for KD are fever, conjunctivitis, mucositis,…”
Get full text
Journal Article -
9
P50 Diagnostic problems in a case of incomplete kawasaki disease
Published in Archives of disease in childhood (01-06-2017)“…IntroductionKawaski disease (KD) is the second most common vasculitis of the childhood. The clinical criteria for KD are fever, conjunctivitis, mucositis,…”
Get full text
Journal Article -
10
Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis–data from the European cystic fibrosis society patient registry
Published in Journal of cystic fibrosis (01-05-2020)“…AbstractBackgroundMonitoring changes in the epidemiology of cystic fibrosis (CF) pathogens is essential for clinical research, quality improvement, and…”
Get full text
Journal Article -
11
DETERMINAREA CONDUCTIVITĂŢII SUDORII ÎN DIAGNOSTICUL FIBROZEI CHISTICE – EXPERIENŢA CENTRULUI REGIONAL SCUC „GRIGORE ALEXANDRESCU
Published in Revista română de pediatrie (01-06-2017)“…Introducere. Testul sudorii este metoda standard pentru diagnosticul fibrozei chistice (FC). Metoda conductivităţii reprezintă o alternativă ce nu este încă…”
Get full text
Journal Article -
12
Impact of CFTR modulatory therapies on liver function and fibrosis indices in cystic fibrosis patients: a retrospective analysis from two Romanian medical centers
Published in Medicine and pharmacy reports (24-10-2024)“…Background. Patients with cystic fibrosis (CF) frequently require modulatory therapies such as Lumacaftor/Ivacaftor (LI) and Elexacaftor/Tezacaftor/Ivacaftor…”
Get full text
Journal Article